|
US Liver disease Articles
US Liver disease News : Liver defect likely cause of DHA deficiency in Alzheimer's patients Thu, 09 Sep 2010 15:54:33 GMT First, let us correct an article we published in our August 25th edition about Dustin Garver. The disease that Dustin has had for 23 years is Cystic Fibrosis not Multiple Sclerosis. The “Hammer” (his nickname) is still at Duke Hospital and is receiving four hours of therapy four days a week.US Liver disease News : In moderation, a little boost of caffeine OK for most of us Fri, 10 Sep 2010 10:05:02 GMT Caffeine is reported to be one of the most widely used drugs, with an estimated 80 percent to 90 percent of American adults consuming caffeinated beverages every day.For biotechs, no easy task Fri, 10 Sep 2010 09:48:26 GMT Hepatitis C, a serious medical problem around the world, is also one of the most important disease targets for the state’s biotechnology industry. Hepatitis C - Biotechnology - Hepatitis - Business - HealthEmbryonic Stem Cell Research Federal Funding Ban Lifted For The Moment Fri, 10 Sep 2010 00:23:35 GMT A US appeals court has just suspended a ban imposed by US District Judge Royce Lamberth last month, meaning that for the moment federal funds can continue supporting embryonic stem cell research. A Washington court has placed a temporary stay on Lamberth's decision. Experts throughout the USA have criticized the ban, which former President George Bush kept in place, saying numerous patients with ...Family offers to swap livers Fri, 10 Sep 2010 07:20:10 GMT The family of a critically ill man is willing to undergo a liver swap with a donor in order to save him.Cholesterol-Lowering Drugs May Cut RA Risk Fri, 10 Sep 2010 07:31:14 GMT Title: Cholesterol-Lowering Drugs May Cut RA Risk Category: Health News Created: 9/9/2010 10:48:00 AM Last Editorial Review: 9/9/2010 10:48:08 AMFDA warns of deadly side effect with imaging drugs Thu, 09 Sep 2010 17:02:47 GMT WASHINGTON —Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.Wyss: Transplant recipient starts foundation Fri, 10 Sep 2010 04:57:07 GMT McHenry resident Donna Frett is among those who are alive today because others thought highly enough of their fellow human beings to sign up as organ donors.Mother given weeks to live after cancer was missed by ELEVEN doctors Thu, 09 Sep 2010 14:26:31 GMT Angela Skeffington claims 10 doctors at Heartlands Hospital, Birmingham, and her own GP misdiagnosed the disease as period pains, depression and indigestion.Cholesterol-Lowering Drugs May Cut RA Risk Wed, 08 Sep 2010 23:09:11 GMT People who take cholesterol-lowering statin drugs to reduce heart disease risk may also be cutting their risk for developing the painful inflammatory joint disease rheumatoid arthritis.Long-time Vermont journalist Sally Johnson dies Fri, 10 Sep 2010 07:36:04 GMT MONTPELIER – Sally Johnson, a long-time Vermont editor and journalist who chronicled the rise of Madeleine Kunin and Bernard Sanders in state politics, died Wednesday night after a lengthy illness. ... - By Daniel Barlow VERMONT PRESS BUREAUVermont journalist Sally Johnson dies Fri, 10 Sep 2010 07:04:36 GMT Long-time Vermont journalist and editor Sally Johnson died Wednesday night. ... - By Daniel Barlow VERMONT PRESS BUREAUCancer Survivor Shares Story Fri, 10 Sep 2010 03:41:38 GMT She's 34, has 3 kids, and a Colorado Springs mother is in the fight of her life. She was diagnosed with breast cancer just six months ago.Joanna Dolgoff, M.D.: Are Detox Diets Safe or Effective? Thu, 09 Sep 2010 18:43:59 GMT How effective can a few days of restriction really be when we are eating garbage the rest of the time?Christopher Kennedy Lawford: A Personal Plea for Better HIV & Hepatitis Prevention Policy Thu, 09 Sep 2010 17:00:17 GMT It is time for California to catch up with the rest of the world on making clean syringes accessible. We have that option through two good bills that Governor Schwarzenegger should sign.FDA to Use Ariana's Data-Mining Tool to Analyze Gene Targets in VXDS Program Wed, 08 Sep 2010 19:55:04 GMT The US Food and Drug Administration will be using Ariana Pharma's data-mining platform to identify genomic markers with the potential to personalize drugs.Wisconsin Governor Pushes For Stem Cell Research Federal Funding Thu, 09 Sep 2010 19:08:45 GMT Wisconsin will join nationwide efforts to make sure federal funding reaches stem cell scientists in his state, Governor Jim Doyle announced. An injunction was granted by U.S. District Court Judge, Royce Lambeth which barred federal funding of human embryonic stem cell research. Governor Doyle said: Wisconsin is home to over 600 biotechnology companies and 11 stem cell companies. In total, there ...NIH to use BP cash to study oil spill health effects Wed, 08 Sep 2010 16:49:29 GMT The U.S. National Institutes of Health said on Tuesday it would use $10 million from BP to start a multiyear study to look at the potential health effects from the oil spill in the Gulf of Mexico.US to use BP cash to study spill health effects Tue, 07 Sep 2010 20:29:30 GMT Study to look at physical, mental health concerns. 8 Sep 2010 6:15 AMAnimals and human health Wed, 08 Sep 2010 21:21:39 GMT Communicating with our pets brings us a lot of positive emotions. And it has been known since ancient times that they also positively affect the health of their masters.'It turns your life upside down' Thu, 09 Sep 2010 20:21:21 GMT Photo by: Nick Lovejoy, Staff Photographer Ty Murray, 3, held his arms out like Buzz Lightyear from the "Toy Story" series as he did the character's famous line, "To infinity and beyond." He jumped on his dad's back and giggled when his mom hugged him. His dark eyes lit up as he handed plates of plastic food to guests at his grandparents' house on Line Street, where they watch him a couple days ...FDA Strengthens Warnings on Gadolinium MRI Dyes Thu, 09 Sep 2010 16:21:29 GMT Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA) to help detect abnormalities of body [...]Criticism rises as zoo deaths mount Thu, 09 Sep 2010 20:36:10 GMT A government investigation into numerous deaths at the Kyiv Zoo, recognized as one of the world’s worst, has been criticized by animal rights activists as a whitewash.Jennerex And Transgene Enter Into An Exclusive Partnership For The Development And Commercialization Of JX-594 For The ... Thu, 09 Sep 2010 11:25:36 GMT Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and ...Your Space: Getting the 'perfect body' or giving into media fads? Thu, 09 Sep 2010 06:05:44 GMT Teens deal with weight perceptions and eating disorders.Why Alcohol Is Good for You Wed, 08 Sep 2010 18:18:53 GMT New research confirms that alcohol can be beneficial to your health. In fact, abstaining from alcohol increases your risk of dying.Should bullfighting be banned? Wed, 08 Sep 2010 18:39:45 GMT Catalonia has voted to outlaw the traditional sport. What will this mean?NIH statement on National HIV/AIDS and Aging Awareness Day Sept. 18, 2010 Thu, 09 Sep 2010 15:21:38 GMT Older HIV-infected adults face unique health challenges stemming from age-related changes to the body accelerated by HIV infection, the side effects of long-term treatment for HIV, the infection itself and often, treatments for age-associated illnesses. Sept. 18 marks the third annual National HIV/AIDS and Aging Awareness Day, an opportunity to highlight these challenges and the research under ...Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress Thu, 09 Sep 2010 17:40:43 GMT WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that results from the Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) will be presented at the 35th European Society of Medical Oncology (ESMO) Congress — Milan, Italy from October 8-12, 2010 ...Nottingham City Hospital Chooses Quality, Throughput and Flexibility With TomoTherapy(R) Radiation Therapy System for ... Thu, 09 Sep 2010 12:21:51 GMT MADISON, WI--(Marketwire - September 9, 2010) - TomoTherapy Incorporated ( NASDAQ : TOMO ), maker of advanced, integrated radiation therapy solutions for cancer care, today announced that its technology will soon be used to treat cancer patients in Nottingham, England. The Nottingham Radiotherapy Centre will install the TomoTherapy ® Hi·Art ® treatment system in November as part of a service ...Vertex's Telaprevir Encourages Wed, 08 Sep 2010 15:38:55 GMT Recently, Vertex Pharmaceuticals announced positive results from a late-stage study of its lead pipeline candidate, telaprevir.BMY to take ZGEN Under its Wings Wed, 08 Sep 2010 14:49:24 GMT Bristol-Myers Squibb Company announced its decision to acquire ZymoGenetics Inc. for $9.75 per share in cash.Nottingham City Hospital Chooses Quality, Throughput and Flexibility With TomoTherapy(R) Radiation Therapy System for ... Thu, 09 Sep 2010 12:00:00 GMT MADISON, WI--(Marketwire - 09/09/10) - TomoTherapy Incorporated (NASDAQ: TOMO - News ), maker of advanced, integrated radiation therapy solutions for cancer care, today announced that its technology will soon be used to treat cancer patients in Nottingham, England. The Nottingham Radiotherapy Centre will install the TomoTherapy Hi-Art treatment system in November as part of a service expansion ...Ohioville liver donor struggles, but not with regret Tue, 07 Sep 2010 02:50:48 GMT TimesOnline.com provides news coverage from the Beaver County Times and Ellwood City Ledger about Local News, Sports and Entertainment.Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the ... Wed, 08 Sep 2010 11:14:03 GMT SAN FRANCISCO and ILLKIRCH, France, Sept. 8 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that ...Why Alcohol Is Good For You [Booze] Wed, 08 Sep 2010 18:41:25 GMT # booze It's one of those medical anomalies that nobody can really explain: Longitudinal studies have consistently shown that people who don't consume any alcohol at all tend to die before people who do. At first glance, this makes little sense. More »The Irish Genome and the End of an Era Wed, 08 Sep 2010 15:54:53 GMT Researchers at the University College Dublin have sequenced the first Irish genome , and have found that the Irish are genetically distinct from their European neighbors, says the New Scientist 's Debora MacKenzie.Toxic Metals Pose Risk to Kids Wed, 08 Sep 2010 18:06:28 GMT We have long been writing about heavy metals turning up in a wide range of consumer and children’s products. Now, CNN is reporting that Consumer Reports magazine wrote that tests indicate that “worrisome levels” of these metals have been found in children’s products being sold today, including rain coats, hair barrettes, and jewelry. The Consumer Reports’ [...]Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan Wed, 08 Sep 2010 11:14:23 GMT EMERYVILLE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and ...Cancer missed by 11 doctors Wed, 08 Sep 2010 13:16:24 GMT GRAN given weeks to live 'was treated like a nuisance and fobbed off for months' by docsBed Bug Resurgence an Opportunity for Some Wed, 08 Sep 2010 17:21:48 GMT The Great Bed Bug Comeback apparently isn’t bad news for everyone. According to a new report by The New York Times, some companies are finding that a recent rash of bed bug infestations in hotels, office buildings, apartment buildings and even movie theaters, is good business for them. According to the article, the cost to [...]Press Release Wed, 08 Sep 2010 08:35:03 GMT Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 65% of people overall achieved a sustained viral response (SVR or viral cure) with a telaprevir-based regimen in the pivotal Phase 3 REALIZE study, as compared to 17% of people in the control arm who received pegylated-interferon and ribavirin alone.BPA in Dental Sealants Raises Concerns Wed, 08 Sep 2010 15:21:28 GMT Bisphenol A—BPA—the controversial polycarbonate plastic is at the root of even more controversy. This time, with dental fillings and sealants being used in children. USNews reported that, based on new research, dental fillings and sealants can expose children to BPA; however, while exposure is believed to be “short-lived,” long-term risks are unknown. The dental products involved, [...]Jennerex, Transgene enters partnership to develop JX-594 product for tumor treatment Wed, 08 Sep 2010 08:07:02 GMT Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for ...DARA Announces Analytical Results in Efficacy and Dose Response of KRN5500 in Patients with Chemotherapy Induced ... Wed, 08 Sep 2010 14:00:00 GMT RALEIGH, N.C. -- DARA BioSciences announced today that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.Keeping the pounds off Wed, 08 Sep 2010 00:03:41 GMT Losing weight needs a commitment to change that should not falter, whatever the cost.Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment Wed, 08 Sep 2010 05:37:12 GMT A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical ...Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the ... Wed, 08 Sep 2010 06:00:00 GMT Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene , a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the ...Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan Wed, 08 Sep 2010 07:00:00 GMT Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. |
Infectious and parasitic diseases |
|
|
< Home > |
||